1. Home
  2. GH vs GVA Comparison

GH vs GVA Comparison

Compare GH & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$101.88

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Granite Construction Incorporated

GVA

Granite Construction Incorporated

HOLD

Current Price

$107.99

Market Cap

4.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
GVA
Founded
2011
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
4.5B
IPO Year
2018
1990

Fundamental Metrics

Financial Performance
Metric
GH
GVA
Price
$101.88
$107.99
Analyst Decision
Strong Buy
Hold
Analyst Count
21
3
Target Price
$79.19
$105.00
AVG Volume (30 Days)
2.4M
673.0K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
0.48%
EPS Growth
N/A
68.53
EPS
N/A
3.67
Revenue
$902,569,000.00
$4,236,312,000.00
Revenue This Year
$34.72
$11.29
Revenue Next Year
$26.46
$10.61
P/E Ratio
N/A
$29.47
Revenue Growth
30.38
6.87
52 Week Low
$29.91
$69.08
52 Week High
$112.43
$112.16

Technical Indicators

Market Signals
Indicator
GH
GVA
Relative Strength Index (RSI) 56.90 64.09
Support Level $103.36 $105.38
Resistance Level $109.59 $107.92
Average True Range (ATR) 5.54 2.47
MACD -1.11 0.60
Stochastic Oscillator 42.83 84.45

Price Performance

Historical Comparison
GH
GVA

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About GVA Granite Construction Incorporated

Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.

Share on Social Networks: